Early region 1 of the adenovirus type . genome was replaced with a DNA sequence containing the gene coding for the hepatitis B surface antigen (HBsAg) flanked by the major late promoter from adenovirus 2 and processing and polyadenylylation signals from simian virus 40. In ono type of hybrid virus only the adenovirus 2 major late pi amoter, including just 33 base pairs of the adenovirus type 2 ',-ipartite leader, preceded the coding region of the HBsAg ene. Iri another, this region was preceded by both the adenovir-.i major late promoter and almost the entire tripartite leader. The structure of the substituted sequence in each of the recombinant viral DNAs was identical to that in the plasmids used to construct the viruses. Approximately equivalent amounts of HBsAg-specific mRNA were produced late in infection with each recombinant virus. Although HBsAg production was detected late in infection of the hybrid virus not containing the full tripartite leader sequence, its level V, as
hybrid virus only the adenovirus 2 major late pi amoter, including just 33 base pairs of the adenovirus type 2 ',-ipartite leader, preceded the coding region of the HBsAg ene. Iri another, this region was preceded by both the adenovir-.i major late promoter and almost the entire tripartite leader. The structure of the substituted sequence in each of the recombinant viral DNAs was identical to that in the plasmids used to construct the viruses. Approximately equivalent amounts of HBsAg-specific mRNA were produced late in infection with each recombinant virus. Although HBsAg production was detected late in infection of the hybrid virus not containing the full tripartite leader sequence, its level V, as 1/70th of that obtained with the hybrid virus containing kimis sequence. One likely interpretation is that the presence of the tripartite leader at the 5' end of this mRNA is critical for the synthesis of HBsAg polypeptide in the late stage of infection. HBsAg produced upon infection with the hybrid adenoviruses was glycosylated and secreted into the culture medium as particles that were essentially indistinguishable from the 22-nm particles found in human serum.
Approximately 200,000 persons in the United States are infected each year with hepatitis B virus. Due to the lack of an in vitro propagation system for hepatitis B virus, much of our knowledge of the viral genome comes from studies employing recombinant DNA methodology (1) . The hepatitis B surface antigen (HBsAg) is found in the sera of infected individuals as a 22-nm particle (1, 2) and also as a 42-nm particle (Dane particle) that is the infectious virion (2) . HBsAg is the major antigen of the virus against which neutralizing antibody is directed. Using HBsAg, we describe here the further development of human adenovirus as a system for the introduction of genes into mammalian cells. The large size of the genome coupled with the existence of adenovirus-transformed cell lines (3) allows for insertion of large segments of DNA. Also, during later stages ofinfection, levels of transcription from the major late promoter are high, while cellular protein synthesis is inhibited (4) . However, the majority of mRNAs produced at late times after infection with adenovirus come from a long primary transcript that is processed to yield five families of 3'-coterminal mRNAs.
These mRNAs all have a common 5' nontranslated region, 200 nucleotides in length. This region is called the tripartite leader because it is generated by the splicing of sequences from three distinct regions of the viral genome (5, 6) . In , which contains an insert of Ad5 DNA extending from an EcoRI linker at the left terminus of the adenovirus genome to the HindIII site at map coordinate 17.0. In addition, adenoviral DNA between 1.4 and 9.1 map units (El region) has been deleted from pAC and the unique Xba I site has been placed at this junction. The new plasmids pACH-2 and pACH-9 ( Fig. 2 ) contained the cassette positioned at the Xba I site in either orientation. Cassettes from pACH-2, pACH-5, pHM1, and pHM2 plasmids were positioned at the El region ofAd5 by the technique of homologous recombination (14) . Plasmids pACH-2 and pACH-9 were linearized with HindIII ( Fig. 2A ) and pHM1 and pHM2 were linearized with EcoRI (Fig. 2B) of adenovirus AEl DNA that extends from 9.1 to 100 map units (7, 8) . The 293 cells were transfected with the DNA mixtures, and the cells were overlaid with agar for plaque detection. Approximately 10-15 days after transfection, plaques were picked. These were amplified by infection of small dishes of 293 cells, and culture lysates (minilysates) were prepared when cytopathic effect was complete (3-6 days) . Crude DNA was prepared from the minilysates and analyzed by hybridization to a 32P-labeled HBsAg DNA probe. In all cases over 90% of plaques yielded DNA that hybridized to probe. Stock viruses were subsequently prepared by infection of each 75-cm2 bottle of 293 cells with 1 ml of the minilysate. Stock viruses derived from pACH-2 or pACH-9 were termed AE1H2 or AElH9. Stock viruses derived from pHM1 and pHM2 were termed HM1 and HM2.
Restriction enzyme patterns of AE1H2, AElH9, HM1, and HM2 viral DNA showed the expected fragments of viral DNA that migrated with insert fragments from the plasmid DNA used in construction of the respective virus (data not shown). This demonstrates that the structure of the hybrid viral DNA was as planned in each case and that there were no rearrangements.
Expression of the HBsAg Gene. To determine the HBsAg expression caused by these hybrid viruses, cell lysates as well as culture supernatants of infected cells were assayed for HBsAg by quantitative RIA. First, minilysates prepared during amplification of viral plaques and known to contain HBsAg DNA by hybridization were assayed. It was found that minilysates from AE1H2-, AElH9-, HM1-, and HM2-infected cells all yielded approximately 1500 cpm, while uninfected or AEl-infected control values were approximately 300 cpm (HM1 plaque 17-2-6 = 1538 cpm; HM2 plaque 1-5 = 1556 cpm; AE1H2 plaque 4 = 1314 cpm; AElH9 plaque 17 = 1405 cpm; AE1 plaque = 250 cpm). These RIA values, although low (approximately 26 ng/5 x 106 cells), indicated the production of small amounts ofHBsAg from all the hybrid viruses during amplification of plaques.
Next, stock viruses were analyzed. Fig. 3 shows the kinetics of synthesis and excretion of HBsAg when the 293 cells were infected with these stock viruses and the culture medium was assayed with a RIA. With HM1 and HM2 shown) .
Surprisingly, AE1H2 or AE1H9 viruses showed very little HBsAg production, either in culture supernatants (Fig. 3) or in culture lysates (data not shown), when 1 ml of stock virus was used to infect a 75-cm2 flask. Small but consistently detectable amounts of HBsAg were observed, however, when culture supernatants of these infected cells were concentrated 10-to 100-fold either by ultracentrifugation or by precipitation with polyethylene glycol 6000 (15 Characterization of the Expressed HBsAg. The most numerous particles in the sera of hepatitis carriers are spherical and have an average diameter of about 22 nm. The biophysical properties of these 22-nm particles are well documented (16, 17) . Some biophysical properties of the HBsAg secreted from cells infected with hybrid adenovirus were examined. The 293 cells were infected with HM1 virus and, 40 hr after infection, the culture medium was clarified, concentrated, and subjected to equilibrium sedimentation through a discontinuous CsCl gradient. Fig. 4A shows that HBsAg, as determined by RIA, migrated to a position corresponding to a buoyant density of 1.20 g/cm3. This value is slightly lower than that (1.22 g/cm3) of particles found in human serum on a parallel gradient. Fig. 4B shows the similarity of the sedimentation velocities of the HBsAg particles from the two sources in a sucrose gradient.
HBsAg Polypeptides. HBsAg consists of two major polypeptides (18, 19) . These are a protein termed P1 (Mr = 22,000-25,000) and a glycoprotein termed P2 (Mr = 28,000-30,000). Fig. 5 shows that when HM-1-infected cells were metabolically labeled with L-[35S]cysteine two polypeptides of approximate molecular weights of 23,000 and 29,000 were specifically immunoprecipitated from culture supernatants by a monoclonal antibody against HBsAg. These proteins migrated with an '25I-labeled HBsAg from human serum.
HBsAg-Specific mRNA. Because of the very large difference in the HBsAg production (Fig. 3) between adenovirus hybrids not containing the full tripartite leader as a part of the HBsAg cassette (AE1H2 and AE1H9) and hybrids containing this sequence (HM1 and HM2), the level of HBsAg-specific mRNA produced upon infection with these viruses was assessed. In each instance poly(A)+ RNA was isolated 40 hr after infection, treated with glyoxal to denature RNA, and fractionated on an agarose gel. The RNA in this gel was transferred to nitrocellulose paper and probed with 32p_ labeled HBsAg DNA (Fig. 6A) The final pellet from polyethylene glycol 6000 precipitation was dissolved in 1.0 ml of 10 mM Tris HCI, pH 7.5, and a portion (0.5 ml) was layered on a 12-ml discontinuous 1.1-1.4g/cm3 CsCl gradient in 10 mM Tris HCI, pH 7.5, and centrifuged at 30,000 rpm at 50C for 24 hr in a Beckman SW 41 rotor. Fractions (0.5 ml) were collected and 10 W.d of each was assayed for HBsAg by RIA (e).
The density of each fraction was also determined (A). Human serum containing HBsAg (the positive control in the RIA kit) was fractionated in a parallel gradient and the peak HBsAg fraction is indicated (I ). (B) A portion (0.5 ml) of the concentrated HBsAg from the medium of HM1-infected cells was layered on a 12-ml 5-30% sucrose gradient in 10 mM Tris HCI, pH 7.5, and centrifuged at 40,000 rpm at 54C for 4 hr in a Beckman SW 41 rotor. Fractions (0.5 ml) were collected and a portion (100 FdI) was assayed as above. A, HM1 culture medium; 0, positive control from HBsAg RIA kit.
the relative sizes ofthe mRNAs as observed in to AE1H9 hexon mRNA of 1.0:0.97:0.56. It therefore appears that the slight differences in the level of HBsAg-specific mRNA between AE1H9 and HM1 or HM2 viruses cannot account for the large differences in HBsAg production (Fig. 3) between these viruses.
DISCUSSION
We describe here the preparation of infectious hybrid adenoviruses that express HBsAg under the control of the adenovirus major late promoter upon infection of human cells. This shows that the expression of a heterologous viral surface glycoprotein is possible by use of adenovirus as vector. The HBsAg polypeptide appears to be glycosylated and is secreted from the adenovirus-infected cells. We have found that biophysical properties of this secreted HBsAg, such as buoyant density and sedimentation rate, are similar or identical to those of the HBsAg obtained from human serum. Constructs analogous to AE1H2 and AE1H9, using the same site (33 bp past the RNA transcription start) as a junction between promoter and structural gene, have been previously shown to elicit production of substantial quantities of SV40 T antigen (7, 10 (21, 22) at 40 hr from the infected 293 cells described in the legend to Fig. 3 (24) and probed with 32P-labeled pBRO3, a plasmid contaihing the gene for HBsAg cloned at the BamHI site of pBR322 (A). In B the HBsAg probe was removed from the nitrocellulose paper by boiling and the paper was reprobed with 32P-labeled oligonucleotides complementary to Ad5 hexon mRNA (CCCTGCGAGTGGCGCATA and GGGGTTTCTAAACTTGTT). Positions of market polynucleotides are indicated by arrows.
share a common 5' nontranslated region, the adenovirus tripartite leader, it has been considered a prime candidate as an element that modulates utilization of these RNAs. Recently, several groups have compared the in vivo and in vitro production of various proteins from mRNAs containing or lacking the adenovirus tripartite leader (12, (25) (26) (27) . In each instance it has been concluded that the tripartite leader sequence, probably in its entirety, is necessary for the best utilization of these mRNAs in adenovirus-infected cells. We have constructed t~vo viruses, HM1 and HM2, containing this tripartite leader sequence. HM1 virus contains an extra 19 bp of SV40 sequence between the end of the adenovirus tripartite leader and the beginning of HBsAg. The slightly enhanced production exhibited by HM2 over HM1 virus may have resulted from deletion of the extra 19-bp SV4O sequence; it has been previously suggested that the distance between the initiation codon and the tripartite leader appears to be important (25) This rather wide disparity in reported effectiveness of the tripartite leader in different mRNAs may also be a measure of the effectiveness of sequences on the heterologous inRNAs in competition with adenovirus mRNAs that contain the complete tripartite leader sequence. For instance, it has been previously observed that cellular RNAs are displaced from large polyribosomes in cells infected by adenovirus alone (28) . However, it has also been shown recently that influenza virus mRNAs can be translated at essentially the same levels in late adenovirus-infected cells as in cells not infected with adenovirus (29) . This indicates that influenza viral mRNA can completely escape the block exerted by adenovirus against host-cell mRNA expression. The exact mechanisms involved in all of these cases of selective mRNA utilization, however, remain undetermined.
